よむ、つかう、まなぶ。
【参考資料6】抗微生物薬適正使用の手引き 第三版 補遺 (31 ページ)
出典
| 公開元URL | https://www.mhlw.go.jp/stf/newpage_45318.html |
| 出典情報 | 厚生科学審議会 感染症部会 薬剤耐性（AMR）に関する小委員会 抗微生物薬適正使用（AMS）等に関する作業部会（第6回 11／19）《厚生労働省》 |
ページ画像
ダウンロードした画像を利用する際は「出典情報」を明記してください。
低解像度画像をダウンロード
プレーンテキスト
資料テキストはコンピュータによる自動処理で生成されており、完全に資料と一致しない場合があります。
テキストをコピーしてご利用いただく際は資料と付け合わせてご確認ください。
引用文献
1.
Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's principles and practice of
infectious diseases. 9th ed. Philadelphia: Elsevier. 2019.
2.
Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of Adverse Events With
Antibiotic Use in Hospitalized Patients. JAMA Intern Med. 2017 Sep;177(9):1308-1315.
3.
Gurtler N, Erba A, Giehl C, Tschudin-Sutter S, Bassetti S, Osthoff M. Appropriateness of
antimicrobial prescribing in a Swiss tertiary care hospital: a repeated point prevalence
survey. Swiss Med Wkly. 2019 Oct;149:w20135.
4.
Komagamine J, Yabuki T, Kobayashi M, Okabe T. Prevalence of antimicrobial use and active
healthcare-associated infections in acute care hospitals: a multicentre prevalence survey in
Japan. BMJ Open. 2019 Jun;9(6):e027604.
5.
Bougle A, Tuffet S, Federici L. et al. Comparison of 8 versus 15 days of antibiotic therapy for
Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized,
controlled, open-label trial. Intensive Care Med. 2022 Jul;48(7):841-849.
6.
Kalil AC, Metersky ML, Klompas M. et al. Management of Adults With Hospital-acquired and
Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious
Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016
Sep;63(5):e61-e111.
7.
Gupta K, Hooton TM, Naber KG. et al. International clinical practice guidelines for the
treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the
Infectious Diseases Society of America and the European Society for Microbiology and
Infectious Diseases. Clin Infect Dis. 2011 Mar;52(5):e103-20.
8.
Lafaurie M, Chevret S, Fontaine JP. et al. Antimicrobial for 7 or 14 Days for Febrile Urinary
Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled,
Randomized Clinical Trial. Clin Infect Dis. 2023 Jun;76(12):2154-2162.
9.
Hooton TM, Bradley SF, Cardenas DD. et al. Diagnosis, prevention, and treatment of
catheter-associated urinary tract infection in adults: 2009 International Clinical Practice
Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010
Mar;50(5):625-663.
10. McAteer J, Lee JH, Cosgrove SE. et al. Defining the Optimal Duration of Therapy for
Hospitalized Patients With Complicated Urinary Tract Infections and Associated Bacteremia.
Clin Infect Dis. 2023 May;76(9):1604-1612.
11. Cranendonk DR, Opmeer BC, van Agtmael MA. et al. Antibiotic treatment for 6 days versus
12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebocontrolled, non-inferiority trial. Clin Microbiol Infect. 2020 May;26(5):606-612.
12. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and
management of skin and soft tissue infections: 2014 update by the Infectious Diseases
Society of America. Clin Infect Dis. 2014;59:e10-52.
13. JAID/JSC 感染症治療ガイド・ガイドライン作成委員会 JAID/JSC 感染症治療ガイド 2019.
ライフサイエンス出版;2019
31
1.
Bennett JE, Dolin R, Blaser MJ. Mandell, Douglas, and Bennett's principles and practice of
infectious diseases. 9th ed. Philadelphia: Elsevier. 2019.
2.
Tamma PD, Avdic E, Li DX, Dzintars K, Cosgrove SE. Association of Adverse Events With
Antibiotic Use in Hospitalized Patients. JAMA Intern Med. 2017 Sep;177(9):1308-1315.
3.
Gurtler N, Erba A, Giehl C, Tschudin-Sutter S, Bassetti S, Osthoff M. Appropriateness of
antimicrobial prescribing in a Swiss tertiary care hospital: a repeated point prevalence
survey. Swiss Med Wkly. 2019 Oct;149:w20135.
4.
Komagamine J, Yabuki T, Kobayashi M, Okabe T. Prevalence of antimicrobial use and active
healthcare-associated infections in acute care hospitals: a multicentre prevalence survey in
Japan. BMJ Open. 2019 Jun;9(6):e027604.
5.
Bougle A, Tuffet S, Federici L. et al. Comparison of 8 versus 15 days of antibiotic therapy for
Pseudomonas aeruginosa ventilator-associated pneumonia in adults: a randomized,
controlled, open-label trial. Intensive Care Med. 2022 Jul;48(7):841-849.
6.
Kalil AC, Metersky ML, Klompas M. et al. Management of Adults With Hospital-acquired and
Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious
Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016
Sep;63(5):e61-e111.
7.
Gupta K, Hooton TM, Naber KG. et al. International clinical practice guidelines for the
treatment of acute uncomplicated cystitis and pyelonephritis in women: A 2010 update by the
Infectious Diseases Society of America and the European Society for Microbiology and
Infectious Diseases. Clin Infect Dis. 2011 Mar;52(5):e103-20.
8.
Lafaurie M, Chevret S, Fontaine JP. et al. Antimicrobial for 7 or 14 Days for Febrile Urinary
Tract Infection in Men: A Multicenter Noninferiority Double-Blind, Placebo-Controlled,
Randomized Clinical Trial. Clin Infect Dis. 2023 Jun;76(12):2154-2162.
9.
Hooton TM, Bradley SF, Cardenas DD. et al. Diagnosis, prevention, and treatment of
catheter-associated urinary tract infection in adults: 2009 International Clinical Practice
Guidelines from the Infectious Diseases Society of America. Clin Infect Dis. 2010
Mar;50(5):625-663.
10. McAteer J, Lee JH, Cosgrove SE. et al. Defining the Optimal Duration of Therapy for
Hospitalized Patients With Complicated Urinary Tract Infections and Associated Bacteremia.
Clin Infect Dis. 2023 May;76(9):1604-1612.
11. Cranendonk DR, Opmeer BC, van Agtmael MA. et al. Antibiotic treatment for 6 days versus
12 days in patients with severe cellulitis: a multicentre randomized, double-blind, placebocontrolled, non-inferiority trial. Clin Microbiol Infect. 2020 May;26(5):606-612.
12. Stevens DL, Bisno AL, Chambers HF, et al. Practice guidelines for the diagnosis and
management of skin and soft tissue infections: 2014 update by the Infectious Diseases
Society of America. Clin Infect Dis. 2014;59:e10-52.
13. JAID/JSC 感染症治療ガイド・ガイドライン作成委員会 JAID/JSC 感染症治療ガイド 2019.
ライフサイエンス出版;2019
31